High quantities of tumor‐infiltrating CD3+ and CD8+ lymphocytes are associated with an improved prognosis in several cancer types [10], and this observation has led to numerous grading systems in an attempt to predict cancer behavior. This evidence concerns the gene CD8A and cancer.